TENXIMA 500: Effective Hemostatic Therapy with Tranexamic Acid (500mg).

TENXIMA 500

Tranexamic Acid 500 mg

TENXIMA 500, containing Tranexamic Acid 500 mg, is a potent antifibrinolytic agent used to prevent and treat excessive bleeding. Tranexamic Acid works by inhibiting the breakdown of fibrin clots, which helps to control bleeding in various medical conditions.

Key Ingredient in TENXIMA 500:

• Tranexamic Acid (500 mg): An antifibrinolytic agent that helps to prevent excessive bleeding by inhibiting plasminogen activation and subsequent fibrinolysis.

Mechanism of Action: Tranexamic Acid works by inhibiting the activation of plasminogen to plasmin, an enzyme that dissolves fibrin clots. By preventing the breakdown of fibrin, Tranexamic Acid stabilizes blood clots and reduces bleeding.

Indications:

• Heavy Menstrual Bleeding: Effective in reducing menstrual blood loss in women with menorrhagia.
• Surgical Procedures: Used to reduce bleeding during and after surgical procedures, including dental surgery, cardiac surgery, and orthopedic surgery.
• Trauma: Helps control bleeding in traumatic injuries.
• Nosebleeds (Epistaxis): Used to manage recurrent nosebleeds.
• Hereditary Angioedema: May be used as a prophylactic treatment to prevent episodes of swelling.

Dosage and Administration:

• Heavy Menstrual Bleeding: The typical dosage is 1000 mg (2 tablets of TENXIMA 500) taken three times a day during menstruation for up to 5 days.
• Surgical Procedures: The dosage varies depending on the type of surgery and the patient's condition. It is usually administered before the procedure and may continue postoperatively.
• Other Indications: The dosage and duration depend on the specific condition being treated and should be determined by a healthcare provider.

Side Effects:

• Common: Nausea, vomiting, diarrhea, and abdominal pain.
• Less Common: Dizziness, headache, and muscle cramps.
• Serious: Visual disturbances, thrombosis, and allergic reactions.

Precautions:

• Thromboembolic Risk: Tranexamic Acid should be used with caution in patients with a history of thromboembolic disease, such as deep vein thrombosis (DVT), pulmonary embolism (PE), or stroke.
• Renal Impairment: Dosage adjustments may be necessary in patients with renal impairment to avoid accumulation and toxicity.
• Allergy: Patients with known hypersensitivity to Tranexamic Acid should avoid using TENXIMA 500.

Monitoring:

• Visual Monitoring: Patients should be monitored for visual disturbances, and the medication should be discontinued if any visual changes occur.
• Thrombosis Monitoring: Regular monitoring for signs of thrombosis is recommended, especially in patients with a history of thromboembolic events.

Conclusion:

TENXIMA 500, with its active ingredient Tranexamic Acid (500 mg), provides effective hemostatic therapy by stabilizing blood clots and reducing excessive bleeding. It is a versatile medication used in various medical conditions, including heavy menstrual bleeding, surgical procedures, trauma, and hereditary angioedema. Healthcare providers should tailor dosages to individual patient needs and monitor for potential side effects to ensure safe and effective use. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW